STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

QURE UNIQURE NV StockScouter® Report

2

StockScouter® Score

UNIQURE NV, a small cap growth company in the healthcare sector, is expected to underperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 20% done.
Low
High

Core Model Grades

D
F
F
F

Previous Ratings

2
6
4